Richard King is EVP & Commercial Operations at KOS PHARMACEUTICALS INC (KOSP). They have made 2 open-market trades across 2 companies since 2006, most recently 2021-06-30.
CIK 0001013702
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $16K since 2011, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ADMS | SELL | 2018-06-21 | 2018-06-22 | $25.48 | $127K | +1.0% | +8.9% | -21.5% |
| ACRX | BUY | 2011-06-09 | 2011-06-13 | $4.56 | $16K | -21.8% | -0.4% | -0.4% |
| KOSP | SELL · 10b5-1 | 2006-03-10 | 2006-03-30 | $50.00 | $250K | N/A | N/A | N/A |
| KOSP | SELL · 10b5-1 | 2006-02-16 | 2006-03-30 | $50.00 | $250K | N/A | N/A | N/A |
| KOSP | SELL · 10b5-1 | 2006-01-03 | 2006-01-04 | $50.38 | $252K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.